Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
44.91
-1.25 (-2.72%)
At close: Apr 24, 2025, 4:00 PM
44.90
-0.01 (-0.01%)
After-hours: Apr 24, 2025, 7:53 PM EDT

Protagonist Therapeutics Market Cap

Protagonist Therapeutics has a market cap or net worth of $2.75 billion as of April 24, 2025. Its market cap has increased by 68.19% in one year.

Market Cap
2.75B
Enterprise Value
2.20B
1-Year Change
68.19%
Ranking
Category
Stock Price
$44.91

Market Cap Chart

Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $2.75B, an increase of 1,505.30%. That is a compound annual growth rate of 37.56%.

History

DateMarket Cap% Change
Apr 23, 20252.83B23.17%
Dec 31, 20242.30B73.94%
Dec 29, 20231.32B146.39%
Dec 30, 2022536.80M-67.11%
Dec 31, 20211.63B111.63%
Dec 31, 2020771.30M302.14%
Dec 31, 2019191.80M17.81%
Dec 31, 2018162.80M-61.78%
Dec 29, 2017426.00M15.89%
Dec 30, 2016367.60M114.34%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 766.16B
UnitedHealth Group 387.92B
Johnson & Johnson 372.76B
AbbVie 317.18B
Novo Nordisk 276.62B
Abbott Laboratories 224.77B
AstraZeneca 213.42B
Novartis AG 208.99B
Market Cap Rankings